Bavarian Nordic upgrades guidance for third time in three weeks

For the third time in three weeks, Bavarian Nordic has increased its stated financial expectations for the year. This comes after a deal was secured with the US government concerning the firm’s monkeypox vaccine.
Photo: LUKAS BARTH/REUTERS / X03379
Photo: LUKAS BARTH/REUTERS / X03379
by christopher due karlsson, translated by catherine brett

Bavarian Nordic has entered into an agreement with the US government concerning the firm’s monkeypox vaccine, and in connection with this, has upgraded its financial guidance again.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading